BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11244050)

  • 21. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
    Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
    Int J Cancer; 2000 Nov; 88(3):439-47. PubMed ID: 11054674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
    Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
    Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor.
    Li C; Chung B; Tao J; Iosef C; Aoukaty A; Wang Y; Tan R; Li SS
    Cell Signal; 2008 Nov; 20(11):1960-7. PubMed ID: 18662772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
    Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
    PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease.
    Lappalainen I; Giliani S; Franceschini R; Bonnefoy JY; Duckett C; Notarangelo LD; Vihinen M
    Biochem Biophys Res Commun; 2000 Mar; 269(1):124-30. PubMed ID: 10694488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.
    Morra M; Silander O; Calpe S; Choi M; Oettgen H; Myers L; Etzioni A; Buckley R; Terhorst C
    Blood; 2001 Sep; 98(5):1321-5. PubMed ID: 11520777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
    Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
    Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.
    Sylla BS; Murphy K; Cahir-McFarland E; Lane WS; Mosialos G; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7470-5. PubMed ID: 10852966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.
    Sayós J; Martín M; Chen A; Simarro M; Howie D; Morra M; Engel P; Terhorst C
    Blood; 2001 Jun; 97(12):3867-74. PubMed ID: 11389028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.
    Rezaei N; Mahmoudi E; Aghamohammadi A; Das R; Nichols KE
    Br J Haematol; 2011 Jan; 152(1):13-30. PubMed ID: 21083659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product.
    Latour S; Gish G; Helgason CD; Humphries RK; Pawson T; Veillette A
    Nat Immunol; 2001 Aug; 2(8):681-90. PubMed ID: 11477403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
    Tangye SG
    J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and diagnosis of X-linked lymphoproliferative disease.
    Gilmour KC; Gaspar HB
    Expert Rev Mol Diagn; 2003 Sep; 3(5):549-61. PubMed ID: 14510176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
    Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.
    Hare NJ; Ma CS; Alvaro F; Nichols KE; Tangye SG
    Int Immunol; 2006 Jul; 18(7):1055-65. PubMed ID: 16720617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.
    Sharifi R; Sinclair JC; Gilmour KC; Arkwright PD; Kinnon C; Thrasher AJ; Gaspar HB
    Blood; 2004 May; 103(10):3821-7. PubMed ID: 14726378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
    Hislop AD; Palendira U; Leese AM; Arkwright PD; Rohrlich PS; Tangye SG; Gaspar HB; Lankester AC; Moretta A; Rickinson AB
    Blood; 2010 Oct; 116(17):3249-57. PubMed ID: 20644117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.
    Parolini O; Kagerbauer B; Simonitsch-Klupp I; Ambros P; Jaeger U; Mann G; Haas OA; Morra M; Gadner H; Terhorst C; Knapp W; Holter W
    Ann Hematol; 2002 Aug; 81(8):441-7. PubMed ID: 12224001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.